Sleep Apnea Monitoring

Proactive management of comorbidities. Early detection, long-term risk reduction. 1–6

Sleep apnea + cardiovascular comorbidities = a dangerous combination

Severe sleep apnea is strongly associated with and has a negative impact on cardiovascular comorbidities:

  • 58% higher risk of heart failure2
  • Risk of atrial fibrillation is 4-times higher3
  • More Resistance to pharmacological treatment4
  • More recurrence of atrial fibrillation after ablation or cardioversion5,6

Sleep apnea is highly prevalent, yet underdiagnosed.7–9

  • 1 out of 4 brady patients (SND or AV block) suffer from severe sleep apnea9
  • 50-90% of patients are undiagnosed and therefore, untreated8

Protect patients with SAM

SAM is a unique Sleep Apnea Monitoring tool which has been validated against the gold standard Apnea Hypopnea Index determined by polysomnography.1

A reliable screening tool, SAM has a high specificity of 85% and a high sensitivity of 89%.

Quick and efficient follow-up

SAM detects and reports severe sleep apnea allowing for quick and efficient follow-up to manage this dangerous disorder.1


This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.

Related products:

ENO ; TEO ; Kora 250; Kora 100; Reply 200; Reply CRT-P;


  1. Defaye P, et al. A pacemaker transthoracic impedance sensor with an advanced algorithm to identify severe sleep apnea: The DREAM European study. Heart Rhythm. 2014;11:842–8.
  2. Gottlieb DJ, Yenokyan G, Newman AB et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122:352–60.
  3. Mehra R, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910–6.
  4. Monahan K, et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2012;110:369–72.
  5. Kanagala R, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589–94.
  6. Ng CY, et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108:47–51.
  7. Bradley TD and Floras JS. Obstructive sleep apnea and its cardiovascular consequences. Lancet. 2009; 373: 82-93.
  8. Lee W, et al. Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med. 2008;2:349–64.
  9. Garrigue S, et al. High Prevalence of Sleep Apnea Syndrome in Patients With Long-Term Pacing: The European Multicenter Polysomnographic Study. Circulation. 2007;115:1703–09.
Exemplary message

By continuing to browse this website you confirm that you are a healthcare professional.